Most-commonly tested cancer biomarkers using NGS in Europe: RAS, BRAF, EGFR Most-commonly tested cancer biomarkers using NGS in Europe… Healthcare | Europe | IVD Gateway | LabPRO Plus | Molecular Diagnostics (MDx) | Sequencing | Tissue Diagnostics (TDx)
Larger gene panels are the predominant NGS testing strategy in EU5 Larger gene panels are the predominant NGS testing strategy… Healthcare | Europe | IVD Gateway | LabPRO Plus | Molecular Diagnostics (MDx) | Sequencing | Tissue Diagnostics (TDx)
Precision medicine and access to NGS cancer biomarker testing in Europe Precision medicine and access to NGS cancer biomarker… Healthcare | Europe | IVD Gateway | LabPRO Plus | Molecular Diagnostics (MDx) | Sequencing | Tissue Diagnostics (TDx)
Proportion of cancer biomarker testing done with NGS expected to double in 2022 compared to 2019 Proportion of cancer biomarker testing done with NGS… Healthcare | Europe | IVD Gateway | LabPRO Plus | Molecular Diagnostics (MDx) | Sequencing | Tissue Diagnostics (TDx)